Contact: Cambridge Healthtech Institute; Last date for abstract submission: Not available; Kinase inhibitor discovery is a very active area as developers explore more deeply into designing immune-modulatory agents as single or combination therapies, tackling chronic disease indications such as inflammation and CNS disorders.